DOV Stock Analysis: Dover | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 27.114m USD | 12M Return: 16.6% | US2600031080 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 286M
EPS Trend: 88.6%
Qual. Beats: 1
Rev. Trend: 51.5%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Dover Corporation is a U.S. industrial manufacturer that supplies equipment, components, consumables, aftermarket parts, software and digital solutions, and support services to customers worldwide. Classified within the Industrials sector (Industrial Machinery & Supplies & Components), the company operates a diversified portfolio organized into five reporting segments that address distinct end-markets.
The Engineered Products segment serves vehicle aftermarket, aerospace and defense, industrial winch and hoist, and fluid dispensing markets. Clean Energy & Fueling provides solutions for fuel and cryogenic gas storage and transport, retail fueling, and vehicle wash operations. Imaging & Identification offers marking, coding, traceability, brand protection, and digital textile printing equipment. Pumps & Process Solutions manufactures specialty pumps, connectors, flow meters, and polymer processing equipment. Climate & Sustainability Technologies produces refrigeration systems, display cases, glass doors, and heat exchangers for commercial and residential climate applications.
Dover was incorporated in 1947 and is headquartered in Downers Grove, Illinois, and trades on the NYSE under the ticker DOV.
- F-gas regulation accelerates refrigeration and heat exchanger replacement demand
- Portfolio reshaping and serial M&A drive sustained margin expansion
- Defense spending and vehicle aftermarket stabilize Engineered Products revenue
| Net Income: 1.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 4.44 > 1.0 |
| NWC/Revenue: 28.10% < 20% (prev 28.99%; Δ -0.89% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.41b > Net Income 1.17b |
| Net Debt (1.82b) to EBITDA (1.93b): 0.94 < 3 |
| Current Ratio: 1.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (134.9m) vs 12m ago -2.28% < -2% |
| Gross Margin: 39.68% > 18% (prev 39.67%; Δ 0.01% > 0.5%) |
| Asset Turnover: 63.30% > 50% (prev 59.04%; Δ 4.26% > 0%) |
| Interest Coverage Ratio: 13.31 > 6 (EBIT TTM 1.54b / Interest Expense TTM 115.6m) |
| A: 0.18 (Total Current Assets 4.96b - Total Current Liabilities 2.55b) / Total Assets 13.7b |
| B: 1.09 (Retained Earnings 14.9b / Total Assets 13.7b) |
| C: 0.11 (EBIT TTM 1.54b / Avg Total Assets 13.5b) |
| D: 1.26 (Book Value of Equity 7.64b / Total Liabilities 6.04b) |
| Altman-Z'' = 6.80 = AAA |
| DSRI: 0.98 (Receivables 1.57b/1.48b, Revenue 8.58b/7.92b) |
| GMI: 1.00 (GM 39.67% / 39.68%) |
| AQI: 0.95 (AQ_t 0.55 / AQ_t-1 0.58) |
| SGI: 1.08 (Revenue 8.58b / 7.92b) |
| TATA: -0.02 (NI 1.17b - CFO 1.41b) / TA 13.7b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of November 14, 2026, the stock is trading at USD 209.95 with a total of 1,010,502 shares traded. Over the past week, the price has changed by +2.99%, over one month by +9.08%, over three months by +1.86% and over the past year by +16.56%.
Current recommended Stop Loss: 198.70 (which is 5.4% or 2.2 ATR below the current price).
Dover has received a consensus analysts rating of 4.42. Therefore, it is recommended to buy DOV.
- StrongBuy: 14
- Buy: 0
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 238.8 | 13.7% |
P/E Trailing = 23.7865
P/E Forward = 17.0358
P/S = 3.1614
P/B = 3.5508
P/EG = 1.3734
Revenue TTM = 8.58b USD
EBIT TTM = 1.54b USD
EBITDA TTM = 1.93b USD
Long Term Debt = 2.58b USD (from longTermDebt, last quarter)
Short Term Debt = 683.4m USD (from shortTermDebt, last quarter)
Debt = 3.51b USD (from shortLongTermDebtTotal, last quarter) + Leases 246.8m
Net Debt = 1.82b USD (calculated: Debt 3.51b - CCE 1.69b)
Enterprise Value = 28.9b USD (27.1b + Debt 3.51b - CCE 1.69b)
Interest Coverage Ratio = 13.31 (Ebit TTM 1.54b / Interest Expense TTM 115.6m)
EV/FCF = 24.38x (Enterprise Value 28.9b / FCF TTM 1.19b)
FCF Yield = 4.10% (FCF TTM 1.19b / Enterprise Value 28.9b)
FCF Margin = 13.84% (FCF TTM 1.19b / Revenue TTM 8.58b)
Net Margin = 13.60% (Net Income TTM 1.17b / Revenue TTM 8.58b)
Gross Margin = 39.68% ((Revenue TTM 8.58b - Cost of Revenue TTM 5.17b) / Revenue TTM)
Gross Margin QoQ = 40.44% (prev 40.21%)
Tobins Q-Ratio = 2.12 (Enterprise Value 28.9b / Total Assets 13.7b)
Interest Expense / Debt = 3.29% (Interest Expense 115.6m / Debt 3.51b)
Taxrate = 19.68% (284.9m / 1.45b)
NOPAT = 1.24b (EBIT 1.54b * (1 - 19.68%))
Current Ratio = 1.95 (Total Current Assets 4.96b / Total Current Liabilities 2.55b)
Debt / Equity = 0.46 (Debt 3.51b / totalStockholderEquity, last quarter 7.64b)
Debt / EBITDA = 0.94 (Net Debt 1.82b / EBITDA 1.93b)
Debt / FCF = 1.53 (Net Debt 1.82b / FCF TTM 1.19b)
Total Stockholder Equity = 7.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.61% (Net Income 1.17b / Total Assets 13.7b)
RoE = 15.43% (Net Income TTM 1.17b / Total Stockholder Equity 7.56b)
RoCE = 15.17% (EBIT 1.54b / Capital Employed (Equity 7.56b + L.T.Debt 2.58b))
RoIC = 10.85% (NOPAT 1.24b / Invested Capital 11.4b)
WACC = 8.17% (E(27.1b)/V(30.6b) * Re(8.89%) + D(3.51b)/V(30.6b) * Rd(3.29%) * (1-Tc(0.20)))
Discount Rate = 8.89% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -85.83 | Cagr: -1.14%
[DCF] Terminal Value 77.97% ; FCFF base≈939.2m ; Y1≈1.08b ; Y5≈1.58b
[DCF] Fair Price = 165.6 (EV 23.8b - Net Debt 1.82b = Equity 22.0b / Shares 133.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 88.59 | EPS CAGR: 6.04% | SUE: 1.17 | # QB: 1
Revenue Correlation: 51.54 | Revenue CAGR: 1.92% | SUE: 0.50 | # QB: 0
EPS current Quarter (2027-03-31): EPS=2.58 | Chg30d=+0.99% | Revisions=+0% | Analysts=12
EPS current Year (2026-12-31): EPS=10.69 | Chg30d=+0.15% | Revisions=+17% | GrowthEPS=+11.2% | GrowthRev=+7.6%
EPS next Year (2027-12-31): EPS=11.78 | Chg30d=+1.19% | Revisions=+42% | GrowthEPS=+10.3% | GrowthRev=+5.6%
[Analyst] Revisions Ratio: +28% (up=24, down=13)